| |
| |
|
| Insider
Information: |
Sandman Paul W |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
329,646 |
|
|
Indirect Shares
|
2,900 |
|
|
| Direct
Value |
$5,464,033 |
|
|
|
Indirect Value
|
$208,887 |
|
|
| Total
Shares |
332,546 |
|
|
| Total
Value |
$5,672,920 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP and General Counsel |
2008-02-29 |
66,846 |
2008-02-29 |
2,900 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2018-06-08 |
262,800 |
2009-04-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2018-06-08 |
4 |
A |
$2.76 |
$150,000 |
D/D |
54,348 |
262,800 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2017-06-09 |
4 |
A |
$2.47 |
$150,001 |
D/D |
60,729 |
208,452 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2016-06-02 |
4 |
A |
$3.52 |
$250,001 |
D/D |
71,023 |
147,723 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2015-05-28 |
4 |
A |
$6.80 |
$150,001 |
D/D |
22,059 |
76,700 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2014-05-28 |
4 |
A |
$9.31 |
$50,004 |
D/D |
5,371 |
54,641 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2013-05-21 |
4 |
A |
$8.37 |
$50,002 |
D/D |
5,974 |
49,270 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2012-06-05 |
4 |
A |
$6.31 |
$50,000 |
D/D |
7,924 |
43,296 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2011-06-22 |
4 |
A |
$5.89 |
$50,000 |
D/D |
8,489 |
35,372 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2010-06-09 |
4 |
A |
$5.05 |
$49,995 |
D/D |
9,900 |
26,883 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2009-06-04 |
4 |
A |
$7.16 |
$49,998 |
D/D |
6,983 |
16,983 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2009-04-08 |
4/A |
B |
$7.38 |
$73,822 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2009-04-08 |
4 |
B |
$7.38 |
$73,822 |
D/D |
10,000 |
52,500 |
2.39 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and General Counsel |
• – – |
2008-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,700 |
79,768 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and General Counsel |
• – – |
2008-02-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,922) |
66,846 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and General Counsel |
• – – |
2007-11-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
45 |
39,068 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and General Counsel |
• – – |
2007-11-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
757 |
39,113 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and General Counsel |
• – – |
2007-07-01 |
4 |
D |
$15.48 |
$51,703 |
D/D |
(3,340) |
38,526 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and General Counsel |
• – – |
2007-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
41,866 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and General Counsel |
• – – |
2007-05-01 |
4 |
AS |
$15.65 |
$5,045,741 |
D/D |
(320,000) |
33,866 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and General Counsel |
• – – |
2007-05-01 |
4 |
OE |
$12.41 |
$3,971,200 |
D/D |
320,000 |
353,866 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and General Counsel |
• – – |
2006-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
606 |
33,866 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
officerTitle |
• – – |
2005-11-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
398 |
32,721 |
|
- |
|
| BSX |
Boston Scientific Corp |
SVP and General Counsel |
• – – |
2003-12-15 |
4 |
AS |
$34.46 |
$1,738,878 |
D/D |
(50,000) |
163,288 |
|
- |
|
| BSX |
Boston Scientific Corp |
SVP and General Counsel |
• – – |
2003-12-15 |
4 |
OE |
$6.13 |
$1,525,629 |
D/D |
181,000 |
213,288 |
|
- |
|
| BSX |
Boston Scientific Corp |
SVP and General Counsel |
• – – |
2003-12-12 |
4 |
AS |
$34.45 |
$10,373,995 |
D/D |
(300,000) |
32,288 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
